Skip to main content
. Author manuscript; available in PMC: 2017 Mar 10.
Published in final edited form as: Endocr Dev. 2015 Dec 17;29:230–239. doi: 10.1159/000438895

Table 3.

Treatment options for FMPP

Drug name Mechanism of action
CPA Antiandrogen
MPA Antiandrogen
Ketoconazole Inhibits P450 enzymes
Spironolactone Weak antiandrogen agent
Testolactone First-generation aromatase inhibitor
Anastrozole Third-generation aromatase inhibitor
Letrozole Third-generation aromatase inhibitor
Bicalutamide Potent nonsteroidal antiandrogen agent